ANXA2 and hepatocellular carcinoma: According to the results of the survival analysis, the expression of ANXA2 (P = 0.00923), C8orf33 (P = 0.04) and IGF2BP3 (P = 0.00313) was significantly correlated with overall survival time of HCC patients (Fig. 7A–C).